10 results for «1925»

Filter By

10 results

Imaging-guided left main PCI - LIVE case

17 May 2024 – From EuroPCR 2024

A 53-year-old male with a history of advanced malignancy (lung adenoma) and mid LAD PCI last year, along with multiple risk factors (hypertension, dyslipidemia, diabetes, and smoking), presented with angina and a positive stress test and CT. The angiography and CT showed significant left main stenosis...

Imaging-guided left main PCI

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

Advanced mitral TEER - LIVE case

24 Nov 2024 – From PCR London Valves 2024

Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:

  • A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Advanced mitral TEER - LIVE case

Transcatheter options for degenerated surgical aortic valves - LIVE case

08 Feb 2025 – From PCR Tokyo Valves 2025

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

Transcatheter options for degenerated surgical aortic valves - LIVE case

Transcatheter management of failed THV - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

Transcatheter management of failed THV - LIVE case

Contemporary strategies for challenging diseases: optimising treatments with ultrathin strut DES

22 May 2019 – From EuroPCR 2019

Consult this session on ultrathin strut drug-eluting stent to learn more about its role in treating complex lesions and patient types, and to discover contemporary approaches to manage various challenging cases, such as ACS STEMI, CTO, and more!

Contemporary strategies for challenging diseases: optimising treatments with ultrathin strut DES

Cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about the cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease, and the clinical strategy for treatment implementation.

Cardiovascular outcomes of SGLT-2 inhibitors and GLP-1 agonists in patients with diabetes and coronary artery disease

Complex PCI in high bleeding risk patients

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to identify high bleeding risk (HBR) patients requiring adjusted antithrombotic strategy and how to tailor PCI strategies to specific HBR patient for drug-device synergy.

Complex PCI in high bleeding

Mechanical circulatory support for protected high-risk PCI: when and how?

21 May 2019 – From EuroPCR 2019

Consult this session on high-risk PCI to learn all about the risks and benefits of mechanical circulatory support, with various clinical cases demonstrating when and how to use it, and how to select the appropriate patient to undergo this procedure.

Mechanical circulatory support for protected high-risk PCI: when and how?

Optimising the generation and regulatory application of clinical evidence in the European Union and the United States

22 May 2019 – From EuroPCR 2019

Consult this session to discover innovative approaches for collecting and utilising clinical evidence, and learn more about how to conduct efficient clinical research to support marketing approval in the European Union, the United States, or regions dependent on the CE mark or FDA approval.

Optimising the generation and regulatory application of clinical evidence in the European Union and the United States
Didn’t find what you were looking for?